Hepatocellular Carcinoma 11 and a Half Years after the Resolution of Chronic Hepatitis C Virus Infection Successfully Treated with Interferon
A 41-year-old Japanese man had received successful interferon (IFN) therapy against chronic hepatitis C in 1994. Since then, serum hepatitis C virus (HCV) RNA had been negative, and aminotransferase levels had been continuously normal. He had abstained from alcohol. However, his serum aminotransfera...
Main Authors: | Naoki Hotta, Minoru Ayada, Akihiko Okumura, Tetsuya Ishikawa, Ken Sato, Tomohiko Oohashi, Yasutaka Hijikata, Shinichi Kakumu |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2009-07-01
|
Series: | Case Reports in Gastroenterology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/225244 |
Similar Items
-
Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals
by: Hye Won Lee, et al.
Published: (2020-11-01) -
Impact of Interferon-α Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma
by: Timokratis Karamitros, et al.
Published: (2018-04-01) -
Enhanced expression of interferon-induced protein with tetratricopeptide repeats 5 promotes migration and invasion of hepatocellular carcinoma cells
by: YANG Nan, et al.
Published: (2020-11-01) -
Simple score to predict risk of hepatocellular carcinoma in chronic hepatitis C patients with advanced fibrosis after pegylated interferon and ribavirin therapy
by: Hu CC, et al.
Published: (2018-04-01) -
Effect of interferons on expression of adenosine deaminase acting on RNA 1 and hepatitis B virus replication in human hepatocellular carcinoma cells in vitro
by: LI Yimin, et al.
Published: (2019-07-01)